ANNOUNCED ONGOING Device recall · Reported 6 Oct 2026 · FDA company announcement, classification pending

StatStrip Glucose Hospital Meter System recalled by Nova Biomedical

Nova Biomedical is recalling StatStrip Glucose Hospital Meter System. The recall was initiated on 5 Oct 2026 and is listed as ongoing.

Recall details

Recall number
FDA-PR-4eb3efc09ac7
Recalling firm
Nova Biomedical
Classification
Pending
Status
Ongoing
Recall initiated
5 Oct 2026
Reported
6 Oct 2026
Reason category
Device Malfunction

Timeline

5 Oct 2026Recall initiated by company
6 Oct 2026Published in enforcement report+1 day

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Software issue may cause a glucose result to be associated to the wrong patient. WALTHAM, Mass., October 5, 2026 – Nova Biomedical initiated a global Medical Device Correction on July 24, 2026, for the StatStrip® Glucose Hospital Meter System due to a software issue that may cause a glucose result to be associated with the wrong patient. When a patient ID barcode is scanned, prior patient information may remain on the meter screen, which if accepted, will lead to glucose result being assigned to the wrong patient’s medical record. If not recognized, healthcare providers may make clinical decisions based on another patient’s glucose result, potentially leading to delayed treatment, unnecessary treatment (including inappropriate insulin administration), and/or failure to treat the intended patient. The severity of harm depends on the patient’s actual glucose status and clinical condition. This issue only applies to the most recent model of the StatStrip Glucose Hospital Meter System, commonly referred to as the “Gen 2.0” model. This issue does not affect previously released models of the StatStrip Glucose Hospital Meter system, commonly referred to as the “Gen 1.0”, “Gen 1.75”,” “Gen 1.86”, or “Gen 1.87” StatStrip Glucose Hospital Meter systems. On July 17, 2026, prior to the recall initiation, Nova Biomedical received one (1) report of an adverse event (AE) in the U.S. (none outside of the U.S.) associated with this issue. This AE involved inappropriate insulin administration to a patient based on a different patient's glucose results. No serious adverse e

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the company

Nova Biomedical StatStrip StatStrip Glucose Hospital Meter System

Where it was distributed

Not stated.

Questions about this recall

Why was it recalled?

Software issue may cause a glucose result to be associated to the wrong patient. WALTHAM, Mass., October 5, 2026 – Nova Biomedical initiated a global Medical Device Correction on July 24, 2026, for the StatStrip® Glucose Hospital Meter System due to a software issue that may cause a glucose result to be associated with the wrong patient. When a patient ID barcode is scanned, prior patient information may remain on the meter screen, which if accepted, will lead to glucose result being assigned to the wrong patient’s medical record. If not recognized, healthcare providers may make clinical decisions based on another patient’s glucose result, potentially leading to delayed treatment, unnecessary treatment (including inappropriate insulin administration), and/or failure to treat the intended patient. The severity of harm depends on the patient’s actual glucose status and clinical condition. This issue only applies to the most recent model of the StatStrip Glucose Hospital Meter System, commonly referred to as the “Gen 2.0” model. This issue does not affect previously released models of the StatStrip Glucose Hospital Meter system, commonly referred to as the “Gen 1.0”, “Gen 1.75”,” “Gen 1.86”, or “Gen 1.87” StatStrip Glucose Hospital Meter systems. On July 17, 2026, prior to the recall initiation, Nova Biomedical received one (1) report of an adverse event (AE) in the U.S. (none outside of the U.S.) associated with this issue. This AE involved inappropriate insulin administration to a patient based on a different patient's glucose results. No serious adverse e

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does an unclassified recall mean?

The FDA assigns a class once it has assessed the health risk. Until then the recall is listed without one.

Read the official FDA notice · Source record retrieved 7 Oct 2026. This is a company announcement published by the FDA; the FDA has not yet classified the recall. The record is updated when the classification appears in the Enforcement Report. This page reports the record and gives no medical advice.

More recalls from Nova Biomedical

All 25

Other Insulin Pumps & Glucose Monitors recalls

All 465